US Patent 9273106 FGF mutants with reduced proteolysis and aggregation
Patent 9273106 was granted and assigned to Amgen on March, 2016 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9273106 FGF mutants with reduced proteolysis and aggregation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
